newsfilter
← Latest News
Business Wire·

Merck Completes Acquisition of Acceleron Pharma Inc.

Merck (NYSE:MRK), known as MSD outside the United States and Canada, today announced the successful completion of the acquisition of Acceleron Pharma Inc. (NASDAQ:XLRN). "This is an important and strategic opportunity for our company to continue grow